Predictors of clinical metastases and survival among nonmetastatic prostate cancer (PC) patients (pts) treated with androgen-deprivation therapy (ADT) in Sweden.
Rohini Khorana Hernandez
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Johan Mesterton
Consultant or Advisory Role - Amgen
Jonas Banefelt
Consultant or Advisory Role - Amgen
Research Funding - Amgen
Jan Stålhammar
No relevant relationships to disclose
Patrik Sobocki
Research Funding - Amgen
Bo-Eric Persson
Employment or Leadership Position - Ferring
Alexander Liede
Employment or Leadership Position - Amgen
Stock Ownership - Amgen